Novel biological therapies for the treatment of diabetic foot ulcers

References

• Diabetes Atlas. International Diabetes Federation. 7th ed. Brussels, 2015.
   Google Scholar
• Ozcan L, Ghorpade DS, Zheng Z, et al. Hepatocyte DACH1 is increased in obesity via nuclear exclusion of HDAC4 and promotes hepatic insulin resistance. Cell Rep. 2016;15:2214–2225.
   PubMed Web of Science ®Google Scholar
• Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29. .
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation-end products: sparking the development of diabetic vascular injury. Circulation. 2006;114:597–605.
   PubMed Web of Science ®Google Scholar
• Kaneto H, Xu G, Song KH, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress. J Biol Chem. 2001;276:31099–31104.
   PubMed Web of Science ®Google Scholar
• Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55:498–510.
   PubMed Web of Science ®Google Scholar
• Abbott CA, Carrington AL, Ashe H, et al. The North-West diabetes foot care study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–384.
   PubMed Web of Science ®Google Scholar
• Amin N, Doupis J. Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153–164.
   PubMed Web of Science ®Google Scholar
• Park SY, Rhee SY, Chon S, et al. Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: an analysis based on the Korea National Diabetes Program Cohort. J Diabetes Complications. 2016 Jun 29;pii:S1056-8727(16)30253-7.
   Google Scholar
• Boulton AJM. The diabetic foot. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; p. 2000–2016.
   Google Scholar
• Tahergorabi Z, Khazaei M. Imbalance of angiogenesis in diabetic complications: the mechanisms. Int J Prev Med. 2012;3:827–838.
   PubMedGoogle Scholar
• Margolis DJ, Allen-Taylor L, Hoffstad O, et al. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen. 2005;13:230–236.
   PubMed Web of Science ®Google Scholar
• Edmonds M. Diabetic foot ulcers. Drugs. 2006;66:913–929. 25: 109-120.
   PubMed Web of Science ®Google Scholar
• Izumi Y, Satterfield K, Lee S, et al. Risk of re-amputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care. 2006;29:566–570. .
   PubMed Web of Science ®Google Scholar
• Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev. 2001;22:36–52.
   PubMed Web of Science ®Google Scholar
• Stirban A, Rösen P, Tschoepe D. Complications of type 1 diabetes: new molecular findings. Mount Sinai J Med. 2008;75:328–351.
   PubMedGoogle Scholar
• Di Marzio D, Mohn A, Mokini ZH, et al. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1). Horm Metab Res. 2006;38:691–705.
   PubMed Web of Science ®Google Scholar
• Yu R, Yekta B, Vakili L, et al. Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides. Curr Atheroscler Rep. 2008;10:171–176.
   PubMed Web of Science ®Google Scholar
• Lotfy M, Adeghate J, Kalasz H, et al. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;13:3–10.
   PubMed Web of Science ®Google Scholar
• Le NN, Rose MB, Levinson H, et al. Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol. 2011;5:605–618.
   PubMedGoogle Scholar
• Moura LI, Dias AM, Carvalho E, et al. Recent advances on the development of wound dressings for diabetic foot ulcer treatment–a review. Acta Biomater. 2013;9:7093–7114.
   PubMed Web of Science ®Google Scholar
• Andros G, Armstrong DG, Attinger CE, et al. Consensus statement on negative pressure wound therapy (V.A.C.Therapy) for the management of diabetic foot wounds. Ostomywound Manage. 2006;Suppl:1–32.
   PubMedGoogle Scholar
• Kessler L, Bilbault P, Ortéga F, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care. 2003;26:2378–2382.
   PubMed Web of Science ®Google Scholar
• Vijaykumar H, Pai SA, Pandey V, et al. Comparative study of collagenase and papain-urea based preparations in the management of chronic non-healing limb ulcers. Indian J Sci Technol. 2011;4:1096–1100.
   Google Scholar
• Karapanagioti EG, Assimopoulou AN. Naturally occurring wound healing agents: an evidence-based review. Curr Med Chem. 2016;23:3285–3321.
   PubMed Web of Science ®Google Scholar
• Hoch RV, Soriano P. Roles of PDGF in animal development. Development. 2003;130:4769–4784.
   PubMed Web of Science ®Google Scholar
• Ma C, Hernandez MA, Kirkpatrick VE, et al. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. Wounds. 2015;27:83–91.
   PubMed Web of Science ®Google Scholar
• Scimeca CL, Bharara M, Fisher TK, et al. Novel use of platelet-rich plasma to augment curative diabetic foot surgery. J Diabetes Sci Technol. 2010;4(5):1121–1126.
   PubMedGoogle Scholar
• Barrientos S, Stojadinovic O, Golinko M, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.
   PubMed Web of Science ®Google Scholar
• Zhou K, Ma Y, Brogan MS. Chronic and non-healing wounds: the story of vascular endothelial growth factor. Med Hypotheses. 2015;85(4):399–404.
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double blind randomized trial. Hum Gene Ther. 2006;17(6):683–691 .
   PubMed Web of Science ®Google Scholar
• Hanft J, Pollak R, Barbul A, et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care. 2008;17(1):30–32, 34–37.
   PubMedGoogle Scholar
• Fernández-Montequín JI, Valenzuela-Silva CM, Díaz OG, et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J. 2009;6:432–443.
   PubMed Web of Science ®Google Scholar
• Ertugrul BM, Lipsky BA, Guvenc U, et al. An assessment of intralesional epidermal growth factor for treating diabetic foot woundsthe first experiences in Turkey. J Am Podiatr Med Assoc. 2017;107:17–29.
   PubMed Web of Science ®Google Scholar
• Dumantepe M, Fazliogullari O, Seren M, et al. Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers. Growth Factors. 2015 Apr;33(2):128–132.
   PubMed Web of Science ®Google Scholar
• Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006;564:394–398; discussion 399-400.
   PubMed Web of Science ®Google Scholar
• Uchi H, Igarashi A, Urabe K, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009 Sep-Oct;19(5):461–468.
   PubMed Web of Science ®Google Scholar
• Richard JL, Parer-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care. 1995;18:64–69.
   PubMed Web of Science ®Google Scholar
• Han SK, Choi KJ, Kim WK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study. Plast Reconstr Surg. 2004;114(7):1783–1789.
   PubMed Web of Science ®Google Scholar
• Blakytny R, Jude EB, Martin Gibson J, et al. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol. 2000 Apr;190(5):589–594.
   PubMed Web of Science ®Google Scholar
• Aydin F, Kaya A, Karapinar L, et al. IGF-1 increases with hyperbaric oxygen therapy and promotes wound healing in diabetic foot ulcers. J Diabetes Res. 2013;2013:567834.
   PubMed Web of Science ®Google Scholar
• Jude EB, Blakytny R, Bulmer J, et al. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med. 2002 Jun;19(6):440–447.
   PubMed Web of Science ®Google Scholar
• Bennett SP, Griffiths GD, Schor AM, et al. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003;90:133–146.
   PubMed Web of Science ®Google Scholar
• Wu L, Xia YP, Roth SI, et al. Transforming growth factor-b1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol. 1999;154:301–309.
   PubMed Web of Science ®Google Scholar
• Vatankhah N, Jahangiri Y, Landry GJ, et al. Effect of systemic insulin treatment on diabetic wound healing. Wound Repair Regen. 2017 Jan 24. DOI:10.1111/wrr.12514
   Web of Science ®Google Scholar
• Fan HJ, Yu JH, Cui GM, et al. Insulin pump for the treatment of diabetes in combination with ulcerative foot infections. J Biol Regul Homeost Agents. 2016;30:465–470.
   PubMed Web of Science ®Google Scholar
• Sun Y, Fan W, Yang W, et al. Effects of intermittent irrigation of insulin solution combined with continuous drainage of vacuum sealing drainage in chronic diabetic lower limb ulcers. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015;29(7):812–817.
   PubMedGoogle Scholar
• Lotfy M, Singh J, Kalász H, et al. Medicinal chemistry and applications of incretins and DPP-4 inhibitors in the treatment of Type 2 diabetes mellitus. Open Med Chem J. 2011;5:82–92.
   PubMedGoogle Scholar
• Seo E, Lim JS, Jun JB, et al. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing. J Transl Med. 2017;15(1):35.
   PubMed Web of Science ®Google Scholar
• Saboo A, Rathnayake A, Vangaveti VN, et al. Wound healing effects of dipeptidyl peptidase-4 inhibitors: an emerging concept in management of diabetic foot ulcer-A review. Diabetes Metab Syndr. 2016 Apr-Jun;10(2):113–119.
   PubMed Web of Science ®Google Scholar
• Karaaltin MV, Baghaki S. Adipose derived regenerative cell therapy for treating a diabetic wound: a case report. Wounds. 2012;24(1):e1–5.
   PubMedGoogle Scholar
• Shi R, Jin Y, Cao C, et al. Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats. Stem Cell Res Ther. 2016;7(1):155.
   PubMed Web of Science ®Google Scholar
• Kato Y, Iwata T, Morikawa S, et al. Allogeneic transplantation of an adipose-derived stem cell sheet combined with artificial skin accelerates wound healing in a rat wound model of Type 2 diabetes and obesity. Diabetes. 2015;64(8):2723–2734.
   PubMed Web of Science ®Google Scholar
• Asai J, Takenaka H, Ii M, et al. Topical application of ex vivo expanded endothelial progenitor cells promotes vascularisation and wound healing in diabetic mice. Int Wound J. 2013;10(5):527–533.
   PubMed Web of Science ®Google Scholar
• Huang G, Sun T, Zhang L, et al. Combined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers. Exp Ther Med. 2014;7(6):1772–1776.
   PubMed Web of Science ®Google Scholar
• Qin HL, Zhu XH, Zhang B, et al. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes. 2016;124:497–503.
   PubMed Web of Science ®Google Scholar
• Benítez-Arvízu G, Í P-L, Vazquez-Campos R, et al. Autologous mesenchymal stem cells and cutaneus autograft as a treatment for chronic ulcer secondary to diabetes mellitus 2. Cir. 2015;83(6):532–536.
   Google Scholar
• Vannini P, Ciavarella A, Mustacchio A, et al. Intra-arterial urokinase infusion in diabetic patients with rapidly progressive ischemic foot lesions. Diabetes Care. 1991;14(10):925–927.
   PubMed Web of Science ®Google Scholar
• Guo J, Meng QH, Yin QY, et al. Study of effect of tongsaimai tablets on experimental diabetic foot model rats. Zhongguo Zhong Yao Za Zhi. 2014;39(11):2091–2096.
   PubMedGoogle Scholar
• Muhammad AA, Arulselvan P, Cheah PS, et al. Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. Drug Des Devel Ther. 2016;10:1715–1730.
   PubMed Web of Science ®Google Scholar
• Steed DL, Ricotta JJ, Prendergast JJ, et al. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care. 1995;18(1):39–46.
   PubMed Web of Science ®Google Scholar
• Cullen B, Watt PW, Lundqvist C, et al. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol. 2002;34:1544–1556.
   PubMed Web of Science ®Google Scholar
• Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, et al. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. Cir Esp. 2007;82:27–31.
   PubMedGoogle Scholar
• Letendre S, LaPorta G, O’Donnell E, et al. Pilot trial of biovance collagen-based wound covering for diabetic ulcers. Adv Skin Wound Care. 2009;22(4):161–166.
   PubMed Web of Science ®Google Scholar
• Wilshaw SP, Kearney J, Fisher J, et al. Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells. Tissue Eng Part A. 2008;14(4):463–472.
   PubMed Web of Science ®Google Scholar
• Asai J, Takenaka H, Hirakawa S, et al. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol. 2012 Dec;181(6):2217–2224.
   PubMed Web of Science ®Google Scholar
• Toker S, Gulcan E, Cayc MK, et al. Topical atorvastatin in the treatment of diabetic wounds. Am J Med Sci. 2009 Sep;338(3):201–204.
   PubMed Web of Science ®Google Scholar
• Kalani M, Apelqvist J, Blombäck M, et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care. 2003 Sep;26(9):2575–2580.
   PubMed Web of Science ®Google Scholar
• Kalani M, Silveira A, Blombäck M, et al. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thromb Res. 2007;120(5):653–661.
   PubMed Web of Science ®Google Scholar
• Lyons TE, Miller MS, Serena T, et al. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg. 2007;193:49–54.
   PubMed Web of Science ®Google Scholar
• Shi E, Shofler D. Maggot debridement therapy: a systematic review. Br J Community Nurs. 2014;Suppl Wound Care:S6–13.
   Google Scholar
• Pinheiro MA, Ferraz JB, Junior MA, et al. Use of maggot therapy for treating a diabetic foot ulcer colonized by multidrug resistant bacteria in Brazil. Indian J Med Res. 2015 Mar;141(3):340–342.
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun XJ, Chen J, et al. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy. J Diabetes Complications. 2017;31:241–244.
   PubMed Web of Science ®Google Scholar
• Netten JJ, Price PE, Lavery LA, et al. Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review. Diabetes/Metabolism Research and Reviews. 2016 Jan 1;32(S1):84–98.
   PubMed Web of Science ®Google Scholar
• Pound N, Chipchase S, Treece K, et al. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005;22(10):1306–1309.
   PubMed Web of Science ®Google Scholar
• Bus SA, Waaijman R, Arts M, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicentre randomized controlled trial. Diabetes Care. 2013;36:4109–4116.
   PubMed Web of Science ®Google Scholar